Clinical Trial

Clinical Characteristics of People With Long-term Type 1 Diabetes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 4, 2022 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Type 1 diabetes (T1D) is characterized by absolute insulin deficiency. Although the discovery and application of exogenous insulin has prolonged the lifespan of T1D patients, the chronic diabetic complications caused by long-term poor glycemic control will still reduce patients' quality of life and the overall life expectancy. According to the studies focused on long-term T1D, part of the patients with long disease duration showed resistance to microvascular complications, and several protective factors have been identified. The prevalence of T1D in China is extremely low compared to that in the western world, and little is known about the characteristics of patients with long-term T1D in China. Therefore, this study is designed to collect variable clinical and laboratory features of patients with long-term T1D, explore the risk and protective factors for the development of microvascular complications, and provide reference for the prediction and prevention of these complications.
Trial Details
NCT Number NCT05359796
Lead Sponsor Second Xiangya Hospital of Central South University
Conditions Type 1 Diabetes
Enrollment 400 participants
Start Date 2022-05-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-05-04